Blaise_logo_splashBlaise_logo_splashBlaise_logo_splashBlaise_logo_splash
  • Home
  • About
    • Overview
    • Market Expertise
      • Biotechnology
      • Pharmaceuticals
      • Medical Devices
      • Contract Services
    • Letter From the Chairman
  • Search Services
    • Search Services
    • CEO
    • Board
    • Executive
    • Sample Placements
  • Search Process
    • Search Process
    • Step-By-Step
    • Diversity Initiatives
    • Succession Planning
  • Strategic Services
  • Client Login
  • Candidate Login
  • News & Events
    • News
    • Events
  • Contact
✕
Pfizer, BioNTech to seek full approval as COVID-19 vaccine efficacy holds up in young teens
November 22, 2021
Investment Banking Prowess Paved Jennifer Jarrett’s Path to Arcus Biosciences
November 22, 2021
Pfizer, BioNTech to seek full approval as COVID-19 vaccine efficacy holds up in young teens
November 22, 2021
Investment Banking Prowess Paved Jennifer Jarrett’s Path to Arcus Biosciences
November 22, 2021
0
Published by at November 22, 2021
Categories
Tags

CStone forged a licensing agreement with Jiangsu Hengrui Pharmaceuticals that grants the company access to a monoclonal antibody aimed at multiple forms of cancer.

CALIFORNIA

Blaise Group International 
Corporate Headquarters

101 Pacifica, Suite 280
Irvine, CA 92618
Telephone: +1 (949) 502-4070
Fax: +1 (949) 502-4069
[email protected]

NEW YORK

Blaise Group International
New York
New York Rockefeller Center
1 Rockefeller Plz, FL 11
New York, NY 10020
Telephone: +1 (917) 588-3700
Fax: +1 (212) 618-6309
[email protected]

LONDON

 Blaise Group International
London

Berkeley Square House
Berkeley Square 2nd Floor
London W1J6BD United Kingdom
Telephone: +44 20 7887 6197
Fax: +44 20 7887 6001
[email protected]

Contact Us

  • This field is for validation purposes and should be left unchanged.

© 2017 Blaise Group International All rights reserved. Orange County Web Design by LightHouse Graphics